Invention Grant
- Patent Title: Nuclease-mediated regulation of gene expression
-
Application No.: US15172626Application Date: 2016-06-03
-
Publication No.: US09957501B2Publication Date: 2018-05-01
- Inventor: Andreas Reik , John A. Stamatoyannopoulos , Jeff Vierstra
- Applicant: Sangamo BioSciences, Inc. , University Of Washington Through Its Center For Commercialization
- Applicant Address: US CA Richmond US WA Seattle
- Assignee: Sangamo Therapeutics, Inc.,University Of Washington
- Current Assignee: Sangamo Therapeutics, Inc.,University Of Washington
- Current Assignee Address: US CA Richmond US WA Seattle
- Agency: Pasternak Patent Law
- Agent Dahna S. Pasternak
- Main IPC: C12N15/85
- IPC: C12N15/85 ; C12N15/52 ; C12N9/22 ; A61K35/28 ; C12N15/10 ; A61K35/12 ; C07K14/805
Abstract:
The present disclosure is in the field of genome engineering, particularly targeted modification of the genome of a hematopoietic cell.
Public/Granted literature
- US20160369262A1 NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION Public/Granted day:2016-12-22
Information query
IPC分类:
